Want to see CTOR full AI Analyst Report?
Citius Oncology (CTOR) Stock Forecast & Price Target
CTOR Analyst Ratings
CTOR Stock 12 Month Forecast
Average Price Target
$4.00▲(622.02% Upside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Michael Okunewitch | Maxim Group | $4 | buy | 622.02%Upside | Reiterated | 10/27/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Michael Okunewitch | 10/27/26 | $4 | buy | 622.02%Upside | Reiterated | Maxim Group |
Best Analysts Covering Citius Oncology
Copying Michael Okunewitch's trades and holding each position for 3 Months would result in 11.11% of your transactions generating a profit, with an average return of -17.92% per trade.
Copying Michael Okunewitch's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -34.02% per trade.
Copying Michael Okunewitch's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -38.29% per trade.
CTOR Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 3 | 3 | 2 | 1 | 2 |
In the current month, CTOR has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CTOR average Analyst price target in the past 3 months is 4.00.
CTOR Financial Forecast
CTOR Earnings Forecast
Next quarter’s earnings estimate for CTOR is -$0.07 with a range of -$0.07 to -$0.07. The previous quarter’s EPS was -$0.08. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
CTOR Sales Forecast
Next quarter’s sales forecast for CTOR is $3.29M with a range of $3.29M to $3.29M. The previous quarter’s sales results were $1.49M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.